Bariatric surgery volumes continue declining as GLP-1 prescriptions for obesity rise sharply from 2017 to 2025, per Ohio ...
People who have used GLP-1 medications—better known by their brand names like Ozempic, Mounjaro or Wegovy—have likely seen meaningful changes in their health, such as improved blood sugar, lower blood ...
GLP-1 medications are reshaping the weight management landscape — and beginning to take a bite out of bariatric surgery volumes in hospitals. Between 2022 and 2023, bariatric surgery rates fell 25.6% ...
The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the ...
More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn't slowing down, resulting in millions of people suffering from health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results